Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | POLA1 | P09884 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | IAPP | P10997 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21360905 | 0.88 | POLB (0.51) | POLBPOLA1PPARGPPARACNR1 | |
| SCHEMBL18812424 | 0.87 | PIK3CD (0.36) | EGFRERBB2PIK3CD | |
| SCHEMBL14165482 | 0.80 | PIK3CD (0.38) | EGFRERBB2PIK3CDMEN1KMT2A | |
| SCHEMBL2842616 | 0.80 | PIK3CD (0.38) | EGFRERBB2PIK3CDMEN1KMT2A | |
| SCHEMBL14165483 | 0.80 | PIK3CD (0.38) | EGFRERBB2PIK3CDMEN1KMT2A | |
| SCHEMBL2842621 | 0.80 | PIK3CD (0.38) | EGFRERBB2PIK3CDMEN1KMT2A | |
| SCHEMBL20230785 | 0.79 | KCNQ3 (0.36) | EGFRERBB2PIK3CD | |
| SCHEMBL21569008 | 0.78 | PIK3CD (0.37) | EGFRERBB2PIK3CD | |
| Hydrochloric Acid SCHEMBL15709158 | 0.78 | PIK3CD (0.37) | EGFRERBB2PIK3CDMEN1KMT2A | |
| SCHEMBL14617834 | 0.78 | HCAR2 (0.41) | EGFRERBB2POLBPIK3CDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3558955-B1 | BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER | AMGEN INC (US) | 2021-08-11 | — | — | EP | disclosed |